Clinical trialNCT00664859CompletedPhase 2/PHASE3Interventional

12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia

SponsorVeloxis PharmaceuticalsEnrollment140Dyslipidemia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The current study is designed to test the long-term (12-month) safety and efficacy of LCP-AtorFen, a combination of atorvastatin and fenofibrate, in patients with dyslipidemia

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Chivers Woodruff, Jr, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Cynthia Strout, MD
Coastal Carolina Research
Study Director
clinicaltrials.gov ↗
Dennis McCluskey, MD
Radiant Resaerch
Study Director
clinicaltrials.gov ↗
Eduardo Cuevas, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Harry Geisberg, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
James Zavoral, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Jeff Geohas, MD
Radiant Research
Principal Investigator
clinicaltrials.gov ↗
Linda Murray, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Mark Kipnes, MD
Diabetes and Glandular Research Center, Inc.
Study DirectorKOL profile →
clinicaltrials.gov ↗
Michael Noss, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Michele Reynolds, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Randall Severance, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Stephen Halpern, MD
Radiant Research
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Radiant Research, 515 N State St, Suite 2700
Chicago, Illinois, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

LCP-AtorFen

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2007
Primary completion: 28 Feb 2009
Completion: 28 Feb 2009
Last update posted: 24 Mar 2020
Registered enrollment: 140
Registry id: NCT00664859

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.